| 000 | 01768 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516022333.0 | ||
| 264 | 0 | _c20110429 | |
| 008 | 201104s 0 0 spa d | ||
| 022 | _a1576-6578 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMerino, J J | |
| 245 | 0 | 0 |
_a[HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system]. _h[electronic resource] |
| 260 |
_bRevista de neurologia _cJan 2011 |
||
| 300 |
_a101-11 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAIDS Dementia Complex _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 |
_aCentral Nervous System _xpathology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEncephalitis _xpathology |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp120 _xmetabolism |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xpathogenicity |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNerve Degeneration _xpathology |
| 650 | 0 | 4 |
_aNeurons _xpathology |
| 650 | 0 | 4 |
_aReceptors, CXCR4 _xmetabolism |
| 650 | 0 | 4 |
_atat Gene Products, Human Immunodeficiency Virus _xmetabolism |
| 700 | 1 | _aMontes, M L | |
| 700 | 1 | _aBlanco, A | |
| 700 | 1 | _aBustos, M J | |
| 700 | 1 | _aOreja-Guevara, C | |
| 700 | 1 | _aBayon, C | |
| 700 | 1 | _aCuadrado, A | |
| 700 | 1 | _aLubrini, G | |
| 700 | 1 | _aCambron, I | |
| 700 | 1 | _aMunoz, A | |
| 700 | 1 | _aCebolla, S | |
| 700 | 1 | _aGutierrez-Fernandez, M | |
| 700 | 1 | _aBernardino, J I | |
| 700 | 1 | _aArribas, J R | |
| 700 | 1 | _aFiala, M | |
| 773 | 0 |
_tRevista de neurologia _gvol. 52 _gno. 2 _gp. 101-11 |
|
| 999 |
_c20551721 _d20551721 |
||